A Novel Framework for Analysis of the Shared Genetic Background of Correlated Traits

Genes (Basel). 2022 Sep 21;13(10):1694. doi: 10.3390/genes13101694.

Abstract

We propose a novel effective framework for the analysis of the shared genetic background for a set of genetically correlated traits using SNP-level GWAS summary statistics. This framework called SHAHER is based on the construction of a linear combination of traits by maximizing the proportion of its genetic variance explained by the shared genetic factors. SHAHER requires only full GWAS summary statistics and matrices of genetic and phenotypic correlations between traits as inputs. Our framework allows both shared and unshared genetic factors to be effectively analyzed. We tested our framework using simulation studies, compared it with previous developments, and assessed its performance using three real datasets: anthropometric traits, psychiatric conditions and lipid concentrations. SHAHER is versatile and applicable to summary statistics from GWASs with arbitrary sample sizes and sample overlaps, allows for the incorporation of different GWAS models (Cox, linear and logistic), and is computationally fast.

Keywords: GWAS; linear combination of traits; proportion of heritability explained by SGF; shared genetic component; shared heritability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genetic Background
  • Genome-Wide Association Study*
  • Lipids
  • Phenotype
  • Polymorphism, Single Nucleotide* / genetics

Substances

  • Lipids

Grants and funding

The work of GRS was supported by the Russian Foundation for Basic Research (project 20-04-00464). The work of Y.A.T. and T.I.A. was supported by the Russian Science Foundation (RSF) grant and Government of the Novosibirsk region No. 22-15-20037. The work of E.E.E. was supported by the grant for the implementation of the strategic academic leadership program “Priority 2030” in Novosibirsk State University. The work of S.Z.S. was supported by budget project No. FWNR-2022-0020. The work of PRHJT was supported by the Medical Research Council Human Genetics Unit (MC_UU_00007/10).